PharmaSGP Holding SE (XTER:PSG) EPS (Basic) : €1.68 (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is PharmaSGP Holding SE EPS (Basic)?

PharmaSGP Holding SE's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was €0.41. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was €1.68.

PharmaSGP Holding SE's EPS (Diluted) for the three months ended in Mar. 2025 was €0.41. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was €1.68.

PharmaSGP Holding SE's EPS without NRI for the three months ended in Mar. 2025 was €0.41. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 1.68.

During the past 12 months, PharmaSGP Holding SE's average EPS without NRIGrowth Rate was 11.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 18.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, PharmaSGP Holding SE's highest 3-Year average EPS without NRI Growth Rate was 18.40% per year. The lowest was -13.40% per year. And the median was 8.00% per year.

PharmaSGP Holding SE EPS (Basic) Historical Data

The historical data trend for PharmaSGP Holding SE's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaSGP Holding SE EPS (Basic) Chart

PharmaSGP Holding SE Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.89

1.00

1.37

1.65

PharmaSGP Holding SE Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.38	0.34	0.45	0.48	0.41

PharmaSGP Holding SE EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

PharmaSGP Holding SE's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(19.535	-	0)	/	11.874
	=	1.65

PharmaSGP Holding SE's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(4.73	-	0)	/	11.537
	=	0.41

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.68

PharmaSGP Holding SE (XTER:PSG) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

PharmaSGP Holding SE EPS (Basic) Related Terms

Thank you for viewing the detailed overview of PharmaSGP Holding SE's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaSGP Holding SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaSGP Holding SE (XTER:PSG) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

PSG:Germany

Address

Lochhamer Schlag 1, Graefelfing, Munich, DEU, 82166

Website

https://www.sgp-pharma.com

PharmaSGP Holding SE is a pharmaceutical company. The company develops chemical-free, over-the-counter (OTC) drugs and healthcare products. The product portfolio includes RUBAXX for rheumatic pain Restaxil for nerve pain, and Deseo for sexual dysfunction. It has established various consumer brands in important indication areas, such as rheumatic and neuralgic pain or sexual weakness Also, the company offers products for skin aging and vertigo.

Executives

Dr. Clemens Fischer	Supervisory Board
Madlena Hohlefelder	Supervisory Board

PharmaSGP Holding SE Headlines

No Headlines